Human corpus luteum physiology and the luteal-phase dysfunction associated with ovarian stimulation

Reproductive BioMedicine Online

Volumn 18, Issue SUPPL. 2, 2009, Pages

  Devoto, Luigi ^a   Kohen, Paulina ^a   Muñoz, Alex ^a   Strauss III, Jerome F ^b  

^a UNIVERSITY OF CHILE   (Chile)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Corpus luteum; Luteal phase; Luteinizing hormone; Ovarian stimulation; Steroidogenic acute regulatory protein

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADOTROPIN; PROGESTERONE; STEROID HORMONE; STEROIDOGENIC ACUTE REGULATORY PROTEIN; VASCULOTROPIN;

ARTICLE; CORPUS LUTEUM FUNCTION; DISEASE ASSOCIATION; EMBRYO TRANSFER; ENDOCRINE GLAND; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; FIRST TRIMESTER PREGNANCY; HUMAN; LUTEAL INSUFFICIENCY; LUTEAL PHASE; LUTEOLYSIS; OVARY CYCLE; OVARY FOLLICLE MATURATION; OVARY HYPERSTIMULATION; OVULATION INDUCTION; STEROIDOGENESIS;

EID: 64949157920     PISSN: 14726483     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1472-6483(10)60444-0     Document Type: Article

References (40)

1. Baerwald AR, Adams GP, Pierson RA 2003 Characterization of ovarian follicular wave dynamics in women. Biology of Reproduction 69. 1023-1031.
2. Carrasco I, Troncoso JL, Devoto L et al. 1996 Differential steroidogenic response of human luteal cell subpopulations. Human Reproduction 11, 1609-1614.
3. Christenson LK, Devoto L 2003 Cholesterol transport and steroidgenesis by the corpus luteum. Reproductive Biology and Endocrinology 1, 90.
4. Csapo AI, Pulkkinen MO, Wiest WG 1973 Effects of luteectomy and progesterone replacement therapy in early pregnant patients. American Journal of Obstetrics and Gynecology 115, 759-765.
5. Del Canto F, Sierralta W, Kohen P et al. 2007 Features of natural and gonadotropin-releasing hormone antagonist-induced corpus luteum regression and effects of in vivo human chorionic gonadotropin. Journal of Clinical Endocrinology and Metabolism 92, 4436-4443.
6. Devoto L, Kohen P, Vega M et al. 2002a Control of human luteal steroidogenesis. Molecular and Cellular Endocrinology 186, 137-141.
7. Devoto L, Vega M, Kohen P et al. 2002b Molecular regulation of progesterone secretion by the human corpus luteum throughout the menstrual cycle. Journal of Reproductive Immunology 55, 11-20.
8. Devoto L, Kohen P, Gonzalez RR et al. 2001 Expression of steroidogenic acute regulatory protein in the human corpus luteum throughout the luteal phase. Journal of Clinical Endocrinology and Metabolism 86, 5633-5639.
9. Devoto L, Vega M, Navarro V et al. 1989 Regulation of steroid hormone synthesis by human corpora lutea: failure of follicle-stimulating hormone to support steroidogenesis in vivo and in vitro. Fertility and Sterility 51, 628-633.
10. Duncan WC, Gay E, Maybin JA 2005 The effect of human chorionic gonadotrophin on the expression of progesterone receptors in human luteal cells in vivo and in vitro. Reproduction 130, 83-93.
11. Duncan WC, McNeilly AS, Fraser HM et al. 1996 Luteinizing hormone receptor in the human corpus luteum: lack of down-regulation during maternal recognition of pregnancy. Human Reproduction 11, 2291-2297.
12. Fatemi HM, Popovic-Todorovic B, Papanikolaou E et al. 2007 An update of luteal phase support in stimulated IVF cycles. Human Reproduction Update 13, 581-590.
13. Fauser BC, Devroey P 2003 Reproductive biology and IVF: ovarian stimulation and luteal phase consequences. Trends in Endocrinology and Metabolism 14, 236-242.
14. Fraser HM, Bell J, Wilson H et al. 2005 Localization and quantification of cyclic changes in the expression of endocrine gland vascular endothelial growth factor in the human corpus luteum. Journal of Clinical Endocrinology and Metabolism 90, 427-434.
15. Fraser HM, Dickson SE, Lunn SF et al. 2000 Suppression of lutcal angiogenesis in the primate after neutralization of vascular endothelial growth factor. Endocrinology 141, 995-1000.
16. Fraser HM, Lunn SF, Harrison DJ et al. 1999 Luteal regression in the primate: different forms of cell death during natural and gonadotropin-releasing hormone antagonist or prostaglandin analogue-induced luteolysis. Biology of Reproduction 61, 1468-1479.
17. Ginther OJ, Beg MA, Gastal EL et al. 2005 Systemic concentrations of hormones during the development of follicular waves in mares and women: a comparative study. Reproduction 130, 379-388.
18. Hillier SG 1991 Paracrine control of follicular estrogen synthesis. Seminars in Reproductive Medicine 9, 332-340.
19. Hosokawa K, Ottander U, Wahlberg P et al. 2001 Dominant expression and distribution of oestrogen receptor beta over oestrogen receptor alpha in the human corpus luteum. Molecular Human Reproduction 7, 137-145.
20. Hubayter ZR, Muasher SJ 2008 Luteal supplementation in in-vitro fertilization: more questions than answers. Fertility and Sterility 89, 749-758.
21. Humaidan P, Bungum L, Bungum M et al. 2006 Rescue of corpus luteum function with peri-ovulatory HCG supplementation in IVF/ICSI GnRH antagonist cycles in which ovulation was triggered with a GnRH agonist: a pilot study. Reproductive BioMedicine Online 13, 173-178.
22. Kerin JF, Broom TJ, Ralph MM et al. 1981 Human luteal phase function following oocyte aspiration from the immediately preovular graafian follicle of spontaneous ovular cycles. British Journal of Obstetrics and Gynaecology 88, 1021-1028.
23. Kiriakidou M, McAllister JM, Sugawara T et al. 1996 Expression of steroidogenic acute regulatory protein (StAR) in the human ovary. Journal of Clinical Endocrinology and Metabolism 81, 4122-4128.
24. Kohen P, Castro O, Palomino A et al. 2003 The steroidogenic response and corpus luteum expression of the steroidogenic acute regulatory protein after human chorionic gonadotropin administration at different times in the human luteal phase. Journal of Clinical Endocrinology and Metabolism 88, 3421-3430.
25. Kupesic S, Kurjak A, Vujisic S et al. 1997 Luteal phase defect: comparison between Doppler velocimetry, histological and hormonal markers. Ultrasound in Obstetrics and Gynecology 9, 105-112.
26. le Nestour E, Marraoui J, Lahlou N et al. 1993 Role of estradiol in the rise in follicle-stimulating hormone levels during the luteal-follicular transition. Journal of Clinical Endocrinology and Metabolism 77, 439-442.
27. Lovely LP, Fazleabas AT, Fritz MA et al. 2005 Prevention of endometrial apoptosis: randomized prospective comparison of human chorionic gonadotropin versus progesterone treatment in the luteal phase. Journal of Clinical Endocrinology and Metabolism 90, 2351-2356.
28. Misao R, Nakanishi Y, Iwagaki S et al. 1998 Expression of progesterone receptor isoforms in corpora lutea of human subjects: correlation with serum oestrogen and progesterone concentrations. Molecular Human Reproduction 4, 1045-1052.
29. Ottander U, Hosokawa K, Liu K et al. 2000 A putative stimulatory role of progesterone acting via progesterone receptors in the steroidogenic cells of the human corpus luteum. Biology of Reproduction 62, 655-663.
30. Richards JS 2007 Genetics of ovulation. Seminars in Reproductive Medicine 25, 235-242.
31. Sanders SL, Stouffer RL 1997 Localization of steroidogenic enzymes in macaque luteal tissue during the menstrual cycle and simulated early pregnancy: immunohistochemical evidence supporting the two-cell model for estrogen production in the primate corpus luteum. Biology of Reproduction 56, 1077-1087.
32. Shikone T, Yamoto M, Kokawa K et al. 1996 Apoptosis of human corpora lutea during cyclic luteal regression and early pregnancy. Journal of Clinical Endocrinology and Metabolism 81, 2376-2380.
33. Sierralta WD, Kohen P, Castro O et al. 2005 Ultrastructural and biochemical evidence for the presence of mature steroidogenic acute regulatory protein (StAR) in the cytoplasm of human luteal cells. Molecular and Cellular Endocrinology 242, 103-110.
34. Stocco C, Telleria C, Gibori G 2007 The molecular control of corpus luteum formation, function, and regression. Endocrine Reviews 28, 117-149.
35. Strauss JF, 3rd, Kallen CB, Christenson LK et al. 1999 The steroidogenic acute regulatory protein (StAR): a window into the complexities of intracellular cholesterol trafficking. Recent Progress in Hormone Research 54, 369-394; discussion 394-365.
36. Tavaniotou A, Smitz J, Bourgain C et al. 2001 Ovulation induction disrupts luteal phase function. Annals of the New York Academy of Sciences 943, 55-63.
37. Vaskivuo TE, Ottander U, Oduwole O et al. 2002 Role of apoptosis, apoptosis-related factors and 17beta-hydroxysteroid dehydrogenases in human corpus luteum regression. Molecular and Cellular Endocrinology 194, 191-200.
38. Vega M, Urrutia L, Iñiguez G et al. 2000 Nitric oxide induces apoptosis in the human corpus luteum in vitro. Molecular Human Reproduction 6, 681-687.
39. Yan Z, Weich HA, Bernart W et al. 1993 Vascular endothelial growth factor (VEGF) messenger ribonucleic acid (mRNA) expression in luteinized human granulosa cells in vitro. Journal of Clinical Endocrinology and Metabolism 77, 1723-1725.
40. Yuan W, Giudice LC 1997 Programmed cell death in human ovary is a function of follicle and corpus luteum status. Journal of Clinical Endocrinology and Metabolism 82, 3148-3155.